Emrah Eraslan
Ankara, 06200, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Clinicopathological Predictors of Pathological Complete Response in HER2-Positive Breast Cancer Treated with Pertuzumab-Based Neoadjuvant Therapy: A Multicenter Real-World Study.
Journal: Medicina (Kaunas, Lithuania)
Published: March 24, 2026
Prognostic Value of the Inflammatory Burden Index (IBI) in Metastatic Urothelial Carcinoma Prior to First-Line Therapy.
Journal: Medicina (Kaunas, Lithuania)
Published: February 19, 2026
Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data.
Journal: Pancreas
Published: October 10, 2023
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.
Journal: Journal of cancer research and clinical oncology
Published: April 05, 2023
The relationship between hemoglobin-RDW ratio and clinical outcomes in patients with advanced pancreas cancer.
Journal: European review for medical and pharmacological sciences
Published: March 17, 2023
Clinicopathological Features and First-Line Treatment Outcomes of Geriatric Patients With Extensive-Stage Small Cell Lung Cancer: A Multicenter Study.
Journal: Cureus
Published: March 02, 2023
Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma.
Journal: Urologic oncology
Published: March 15, 2022
Factors affecting prognosis and treatment strategies in metastatic soft tissue sarcomas: twenty years of experience.
Journal: European review for medical and pharmacological sciences
Published: November 17, 2021
Thirty-day mortality rates after immunotherapy initiation.
Journal: Immunotherapy
Published: October 22, 2021
Last Updated: 09/26/2026